Hansen SH, Maseng MG, Grännö O, Vestergaard MV, Bang C, Olsen BC, Lund C, Olbjørn C, Løvlund EE, Vikskjold FB, Huppertz-Hauss G, Perminow G, Yassin H, Valeur J, Aass Holten KI, Henriksen M, Bengtson MB, Ricanek P, Opheim R, Boyar R, Torp R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VAet al.(2025) Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort Inflamm Bowel Dis(in press) DOI 10.1093/ibd/izaf060, PubMed 40285477
Dahl TB, Aftab F, Prebensen C, Berdal JE, Ueland T, Barratt-Due A, Riise AMD, Ueland PM, Hov JR, Trøseid M, Aukrust P, Gregersen I, Myhre PL, Omland T, Halvorsen B(2025) Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement J Infect, 90(6), 106494(in press) DOI 10.1016/j.jinf.2025.106494, PubMed 40280497
Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A(2025) Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study Hepatology(in press) DOI 10.1097/HEP.0000000000001351, PubMed 40238209